Ustekinumab is an effective and safe therapy in anti-TNF refractory Crohn's Disease: a two year real-life observational study from Spain

Rueda Sanchez, J.Cabello Ramirez, N.Camara Baena, S.Keco Huerga, A.de la Borbolla Serres, J. GarciaCastro Fernandez, M.Grande Santamaria, L.2025-01-072025-01-072021-05-011873-9946https://hdl.handle.net/10668/27120enUstekinumab is an effective and safe therapy in anti-TNF refractory Crohn's Disease: a two year real-life observational study from Spainconference outputopen access10.1093/ecco-jcc/jjab076.4521876-4479https://academic.oup.com/ecco-jcc/article-pdf/15/Supplement_1/S352/38320945/jjab076.452.pdf709432400452